Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Wandercraft is a robotics company founded 2012, based in France, developing 3 robots primarily in the Exoskeleton category.
CAPITAL & EVIDENCE
Wandercraft has raised US$138.0M across 3 confirmed rounds and has 1 known customer, not yet tied to a specific model.
Raised
US$138.0M
across 3 confirmed rounds · latest Jun 2025 · Series D
- Jun 2025· Series D· US$75.0M· investors: Renault Group, PSIM fund, Teampact Ventures +6 more· The Robot Report ↗· 9 outletsCorrect this round
- Jan 2022· Series C· US$45.0M· investors: Quadrant Management, Bpifrance, SofiOuest +8 more· The Robot Report ↗· 2 outletsCorrect this round
- Oct 2017· Series B· US$18.0M· The Robot Report ↗Correct this round
Confirmed rounds recorded from January 2017. Every amount links to its source.
Correct this →Shipped
1 known customer — no deployment yet tied to a specific model
Also cited
- Renault Group· 2025therobotreport.com ↗
- Kessler Foundation· 2023therobotreport.com ↗
Self-balancing robotic exoskeletons and humanoid robots
Wandercraft is a French robotics company that develops self-balancing exoskeletons for rehabilitation and personal mobility, including Atalante X and Eve, and humanoid robots such as Calvin-40 for industrial tasks. It operates from France and has expanded commercialization efforts in the United States through partnerships and clinical programs.
Active products
3
RoboIndex
64.34
RoboScore 58.84 + Momentum 5.50
Company facts
- HQ
- Paris, France
- Founded
- 2012 · 14 yrs
- Stage
- Series D · Jun 2025
- Website
- en.wandercraft.eu
RoboScore
58.84 RoboScore + 5.50 Momentum· Strong evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
5 of 6 factors known. How it's calculated
On the company boards
- #9 of 38·Exoskeleton·best robot 53.49 + depth 1.67 + news 5.50 = total 60.66
- #9 of 39·Surgical / Medical·best robot 54.81 + depth 0.00 + news 5.50 = total 60.31
A board total ranks makers within one category. It is built from the best robot's RoboScore, a capped credit for more ranked robots, and news. It is not this company's RoboIndex above. How boards work
Milestones
Announced Calvin-40, an industrial humanoid robot, alongside a strategic partnership with Renault Group.
Closed a $75 million Series D financing round.
Started clinical trials of the Personal Exoskeleton Eve.
Atalante X received FDA approval for spinal cord injury rehabilitation.
Atalante X was approved by the FDA for stroke rehabilitation.
Began commercial operations in the United States through a partnership with Kessler Foundation.
Press coverage
- Wandercraft unveils Calvin, new industrial humanoid, and Renault invests in French startup
The Robot Report
- What Sets This Exoskeleton Robot Company Apart: $137M Total ...
36Kr
- Wandercraft secures $75M in series D funds for robotics portfolio
BioWorld
- Wandercraft | Globenewswire - Via Ritzau
GlobeNewswire / Via Ritzau · Jun 2025
In the news
4 events · last 90 days
+5.50momentumof 15 maxWandercraft Acquires Ekso Bionics from ChronoScale to Form World's Largest Medical Exoskeleton Powerhouse
In the news
4 events · last 90 days
Why Wandercraft has been in the news, across 10 outlets — collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore — the evidence half of the RoboIndex — and it can move a robot up a board by at most 15 points.
Public loss record
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Active products by Wandercraft
3 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 |  | Atalante X | Surgical / Medical | 2022 | 54.8 |
| 2 |  | Eve | Exoskeleton | 2020 | 53.5 |
| 3 |  | Calvin-40 | Exoskeleton | 2025 | 47.4 |
Exoskeleton buying guides
Industry Knowledge →
The exoskeleton vendor RFP: questions and red flags
Most exoskeleton RFPs focus on spec sheets. The questions that protect you are about fit programs, hygiene, evidence, regulatory clearance, and what happens whe…
A 90-day deployment playbook for industrial exoskeleton programs
A 90-day structured deployment — with ergonomics baseline, task selection, worker fit, hygiene protocol, and measurement — is what separates programs that scale…
Exoskeleton decision framework: passive vs. powered, industrial vs. medical
The exoskeleton market spans four device architectures, two primary buyer types, and dozens of body-region configurations. This framework maps the decision tree…